Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
出版年份 2018 全文链接
标题
Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 9, Issue 6, Pages -
出版商
Springer Nature
发表日期
2018-05-24
DOI
10.1038/s41419-018-0691-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms of lapatinib resistance in HER2-driven breast cancer
- (2015) Valentina D’Amato et al. CANCER TREATMENT REVIEWS
- Mutant p53 Amplifies Epidermal Growth Factor Receptor Family Signaling to Promote Mammary Tumorigenesis
- (2015) Alisha R. Yallowitz et al. MOLECULAR CANCER RESEARCH
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- Mutant p53 – Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival
- (2015) Evguenia M. Alexandrova et al. Frontiers in Endocrinology
- AUY922 Effectively Overcomes MET- and AXL-Mediated Resistance to EGFR-TKI in Lung Cancer Cells
- (2015) Yun Jung Choi et al. PLoS One
- Akt phosphorylates and activates HSF-1 independent of heat shock, leading to Slug overexpression and epithelial–mesenchymal transition (EMT) of HER2-overexpressing breast cancer cells
- (2014) R L Carpenter et al. ONCOGENE
- HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer
- (2014) R Schulz et al. Cell Death & Disease
- Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes
- (2013) Julie C. Friedland et al. INVESTIGATIONAL NEW DRUGS
- Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update
- (2012) Daniel R. Ciocca et al. ARCHIVES OF TOXICOLOGY
- HSF1 Drives a Transcriptional Program Distinct from Heat Shock to Support Highly Malignant Human Cancers
- (2012) Marc L. Mendillo et al. CELL
- Heat Shock Factor Hsf1 Cooperates with ErbB2 (Her2/Neu) Protein to Promote Mammary Tumorigenesis and Metastasis
- (2012) Caixia Xi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis
- (2012) Chengkai Dai et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
- (2011) S. Modi et al. CLINICAL CANCER RESEARCH
- High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
- (2011) S. Santagata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- KRIBB11 Inhibits HSP70 Synthesis through Inhibition of Heat Shock Factor 1 Function by Impairing the Recruitment of Positive Transcription Elongation Factor b to thehsp70Promoter
- (2010) Young Ju Yoon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dual Targeting of HSC70 and HSP72 Inhibits HSP90 Function and Induces Tumor-Specific Apoptosis
- (2008) Marissa V. Powers et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now